Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 18937 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 23138 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 27733 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 27789 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 30373 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 31222 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 37507 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 38105 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 52553 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 55054 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 60556 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 67423 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 69345 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 72858 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 73532 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 73947 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 93985 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 106237 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 106955 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 118455 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 122316 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 123395 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 124583 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 129661 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 135032 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 142439 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 144822 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 146130 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 149457 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 150770 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 157756 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 161254 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 161364 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 162552 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 166205 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 170242 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 171211 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 173584 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 176041 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 177099 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 178163 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 187505 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 195187 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 195907 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 197091 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 198290 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 208336 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 217343 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 217435 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 218412 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 220399 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 220461 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 225123 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 230878 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 240449 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 247422 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 257111 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 264413 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 271501 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 277969 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 281671 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 290230 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 298436 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 301009 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 305130 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 327663 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 333649 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 354560 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 415534 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 417028 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 533493 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 619299 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | Case | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | Case | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | Case | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | Case | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | Case | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | Case | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | Control | N | Exemestane | Black | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | Control | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | Control | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | Control | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |